Lv2
170 积分 2022-03-01 加入
CD3 bispecific antibody-induced cytokine release is dispensable for cytotoxic T cell activity
12小时前
已完结
Immunohistological distribution of 5T4 antigen in normal and malignant tissues
1天前
已完结
T cell–Dependent Bispecific Therapy Enhances Innate Immune Activation and Antibody-Mediated Killing
1天前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
4天前
已完结
Optimization of a Novel 2 + 2 BCMA × CD3 Bispecific Antibody for Minimized Cytokine Release and Potent Efficacy
4天前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
5天前
已完结
Ianalumab plus Eltrombopag in Immune Thrombocytopenia
5天前
已完结
Defining immune reset: achieving sustained remission in autoimmune diseases
1个月前
已完结
Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study
2个月前
已完结
B cells: The many facets of B cells in allergic diseases
2个月前
已完结
皖公网安备34019202002308
